Anhedonia cost-effectiveness of therapy

Revision as of 01:54, 27 March 2014 by Pratik Bahekar (talk | contribs)
Jump to navigation Jump to search

Anhedonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Diagnosis

Diagnostic Criteria

History and Symptoms

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Anhedonia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anhedonia

CDC on Anhedonia

Anhedonia in the news

Blogs on Anhedonia

Directions to Hospitals Treating Anhedonia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Overview

Anhedonia seems to be an important factor influencing prognosis of many diseases. Few studies have shown reduced positive outcome and increased rate of complication in the presence of anhedonia.

Cost-Effectiveness of Therapy

Schizophrenia

  • Elevated levels of social anhedonia in patients with schizophrenia have been linked to poorer social functioning.[1][2]
  • Socially anhedonic individuals perform worse on a number of neuropsychological tests than non-anhedonic participants,[3][4] and show similar physiological abnormalities seen in patients with schizophrenia.[5]

References

  1. Blanchard, J.J., Bellack, A.S., & Mueser, K.T. (1994).
    • Affective and social-behavioral correlates of physical and social anhedonia in schizophrenia. ‘’Journal of Abnormal Psychology, 103’’, 719-728.
  2. Blanchard, J.J., Mueser, K.T., & Bellack, A.S. (i1998). Anhedonia, positive and negative affect, and social functioning in schizophrenia. ‘’Schizophrenia Bulletin, 24’’, 413–424.
  3. Laurent, A., Biloa-Tang, M., Bougerol, T., Duly, D., Anchisi, A.M., Bosson, J.L., Pellat, J., d’Amato, T., & Dalery, J. (2000).
    • Executive/ attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. ‘’Schizophrenia Research, 46’’, 269–283.
  4. Cohen, A., Leung, W., Saperstein, A., & Blanchard, J. (2006). Neuropsychological functioning and social anhedonia: Results from a community high-risk study. ‘’Schizophrenia Research, 85’’, 132−141.
  5. Cohen, A.S., Leung, W.W., Saperstein, A.M., & Blanchard, J.J. (2006). Neuropsychological functioning and social anhedonia: results from a community high-risk study. ‘’Schizophrenia Research, 85’’, 132-141.

Template:WikiDoc Sources